Last reviewed · How we verify
NCT06579027
A Novel Program Using Ride-on Toys to Improve Upper Extremity Function in Children With Hemiplegia
NA trial testing SPEED Training in Hemiplegia in 30 participants. Currently enrolling.
31 July 2026
Quick facts
| Lead sponsor | University of Connecticut |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 26 September 2024 |
| Primary completion | 31 July 2026 |
| Estimated completion | 1 September 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- SPEED Training
- CRAFT Training
Conditions studied
- Hemiplegia — all drugs for Hemiplegia →
- Cerebral Palsy — all drugs for Cerebral Palsy →
- Children, Only — all drugs for Children, Only →
Sponsor
University of Connecticut
Who can join
Adults 3 to 8, any sex, with Hemiplegia or Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to assess the feasibility and utility of 2 types of play-based training programs co-delivered by researchers and caregivers within home/community settings to promote arm function among 3-to-8-year-old children with hemiplegia. Specifically, investigators will assess the feasibility of implementation and acceptance/satisfaction associated with a researcher-caregiver co-delivered community-based training program involving either joystick-operated powered ride-on toys (SPEED training) or creative upper extremity training (CRAFT training). The investigators will also compare the effects of these 2 types of training programs on children's arm motor function and spontaneous use of their affected arm during daily activities.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06579027
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hemiplegia
Currently open trials in the same condition.
- NCT07386119 — Investigation of the Effects of Vestibular Rehabilitation and Dynamic Neuromuscular · NA · active not recruiting
- NCT07304180 — Exergame vs Balance Training in Hemiplegia · NA · active not recruiting
- NCT07261007 — Investigation of the Effectiveness of Flossing in Hemiplegic Patients With Shoulder Pain · NA · recruiting
- NCT07063446 — sTMS Combined With CIMT and taVNS In Infants With Hemiplegia · NA · recruiting
- NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting
Other University of Connecticut trials
Trials by the same sponsor.
- NCT06794840 — JomCare Study - A Harm Reduction Study · NA · not yet recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT06381921 — Objective Integrated Multimodal Electrophysiological Index for the Quantification of Visceral Pain · NA · recruiting
- NCT06393725 — Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions · NA · recruiting
- NCT04989309 — Left and Right Hemisphere Contributions to Speech Perception · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06579027 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Connecticut
- Last refreshed: 5 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06579027.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing